EU to decide on Astrazeneca’s $39 bln Alexion deal by July 5 2021-06-01T08:37:01-04:00June 1st, 2021| share this article! EU antitrust regulators will decide by July 5 whether to clear Anglo-Swedish drugmaker AstraZeneca’s (AZN.L) $39 billion bid for U.S.-based Alexion (ALXN.O), a European Commission filing showed on Tuesday. Read More share this article! Related Posts Peloton Stock Drops 13%. Its CEO Is Stepping Down and There Are Layoffs., Go to article May 2nd, 2024 DJT Stock Is Bouncing Back. Here’s Why., Go to article May 2nd, 2024 U.S. v. Google Antitrust Case Heads to Final Argument. The Stakes Are Sky High., Go to article May 2nd, 2024 Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling., Go to article May 2nd, 2024
